Enzyme-Linked Immunosorbent Assay (ELISA) Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

The Enzyme-Linked Immunosorbent Assay (ELISA) market is segmented by Product (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA), Application (Disease Diagnosis, Vaccine development and Others ) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Enzyme Linked Immunosorbent Assay Market Size
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: >8 %
Enzyme Linked Immunosorbent Assay Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Enzyme-Linked Immunosorbent Assay (ELISA) market is projected to register a CAGR of 8% during the forecast period (2022-2027).

The COVID-19 has increased the demand for the Immunoassays like Enzyme-Linked Immunosorbent Assay (ELISA) across the globe. This is mainly due to the increase in the infection rates, which increased the necessity for effective diagnosis. According to the data published in the National Center for Biotechnology Information (NCBI) Journal in 2020, SARS-CoV-2 can be detected by the Enzyme-Linked Immunosorbent Assay(ELISA) with high accuracy. The increase in the demand for cost-effective and effective diagnosis to get the appropriate treatment is expected to drive the growth of the market.

The increasing incidence of infectious diseases such as HIV, Dengue, Hepatitis malaria, influenza, and various other infections is one of the major factors contributing to the growth of the market. According to the World Health Organization (WHO), there were an estimated 37.7 million people living with HIV at the end of 2020 across the globe, and over two-thirds of them are in the Africa region. Also, the same source stated that dengue fever is one of the top ten global health threats. There has been a 30-fold increase in dengue global incidence over the past 50 years. According to World Health Organization in 2020, Over 354 million people across the globe live with Hepatitis B or C infections. Such increasing incidence of infectious diseases increased the demand for the diagnosis. The increased usage of advanced diagnostic tools such as enzyme linked immunosorbent assay for screening the diseases is attributed to the growth of the market.

Furthermore, the increase in the geriatric population who are at risk of developing various infections, chronic disorders, and in need of regular diagnosis across the globe also plays a crucial role in driving the growth of the market. The National Center for Biotechnology for Information (NCBI) in 2021, reported that potentially serious infections are quite common in older patients than in younger. Such factors are expected to significantly increase the demand of the enzyme-linked immunosorbent assay market , thereby increasing the growth of the market.

Scope of the Report

As per the scope of this report, the Enzyme-Linked Immunosorbent Assay (ELISA) is a commonly used solid-phase type enzyme immunoassay to detect the presence of a ligand in a liquid sample using antibodies directed against the protein to be measured. The Enzyme-Linked Immunosorbent Assay (ELISA) market is segmented by Product (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA), Application (Disease Diagnosis, Vaccine development, and Others) , and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa. The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in ( in USD million) for the above segments.

By Method
Direct ELISA
Indirect ELISA
Sandwich ELISA
Competitive ELISA
By Application
Disease diagnosis
Vaccine Development
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Disease diagnosis Application Segment is Expected to Hold a Major Market Share in the Enzyme-Linked Immunosorbent Assay (ELISA) market Market.

Amidst COVID-19, there is an increasing demand for the enzyme-linked immunosorbent assay market as there is a high prevalence of infection rate during the pandemic period. This increased the demand for the diagnostics kits such as ELISA in the market which propels the growth of the market.

The disease diagnosis segment is expected to hold a major share due to the increasing application of enzyme-linked immunosorbent assay tests in the diagnosis of tumor antigens. According to the World Health Organization (WHO) in 2022, Noncommunicable diseases kill 41 million people each year, equivalent to 71% of all deaths globally. These incidences increased the demand for effective diagnostic tools like ELISA for early diagnosis to prevent life loss. Also, the Global cancer observatory Stated that worldwide an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred in 2020. This increase in cancer cases across the globe increased the demand for Enzyme-Linked Immunosorbent Assay (ELISA). ELISA can serve as an effective tool in measuring cancer markers or antigens. According to the article published in Nature Scientific report in 2020, the Enzyme-Linked Immunosorbent Assay(ELISA) can be used to detect prostate cancer antigens and breast cancer antigens as well. Such cost-effective diagnosis coupled with the accuracy of detection in antigens increased the demand for ELISA and propelled the growth of the market.

Enzyme Linked Immunosorbent Assay Market Trends

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period.

The United States is likely to command the global market owing to the quick adoption of technological advancements in diagnostic tools like Enzyme-Linked Immunosorbent Assay (ELISA). The robust growth of the demand for Enzyme-linked Immunosorbent Assay (ELISA) can be attributed to the increasing prevalence of various infectious and chronic diseases among the people in this region. For instance, the Center for Disease Control and Prevention (CDC) in 2022 stated that six in ten Americans live with at least one chronic disease like heart disease and stroke, cancer, and others. Additionally, the increasing investment into the research and development activities and various funding programs for diagnostic purposes also boost the growth of the market in this region. According to the Binder Dijker Otte (BDO) USA Reports in 2020, companies listed on the biotechnology index (NBI) average research and development spending increased by 16% in 2020 to USD 284.25 million in the United States by the pharmaceutical industry. Also, the Department of Health and Human Services (HHS) stated in 2021 that they will invest USD 650 million from the American rescue plan to strengthen manufacturing capacity for quick, high-quality diagnostic testing. Moreover, the presence of major players in the region is also contributing to the major market share of this region.

Enzyme Linked Immunosorbent Assay Market Growth

Competitive Landscape

The Enzyme-Linked Immunosorbent Assay (ELISA) market is fragmented competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Abcam Plc, Merck kGaA, Bio-Rad Laboratories, Inc, Cell Biolabs, Inc, Promega Corporation, Zeus Scientific, Inc, Enzo Life Sciences, Inc, Arbor Assays, Inc, Biolegend, Agilient Technologies, Inc, J. Mitra & Co. Pvt Ltd and others.

Recent Development

In June 2021, J Mitra and Company has launched the COVID-19 Ag Microlisa ELISA test kit for the Indian market. The test kit will provide better time efficiencies by reducing the turnaround time between testing and results to just two hours.

In April 2021, Promega Corporation announced the opening of a newly constructed research and development facility on its Fitchburg, WI campus. This will support their core product and technology development in research and development.

In April 2021, Thermo fisher scientific Inc. announced that they will acquire PPD company for
USD 47.50 per share for a total cash purchase price of USD 17.4 billion. The company Thermo fisher acquired PPD for their expansion into clinical research services.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Chronic and Infectious Diseases

      2. 4.2.2 Growing Awareness Among the People for Early Diagnosis

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations for Approval

      2. 4.3.2 Lack of Skilled Personnel for Handling the Equipment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Method

      1. 5.1.1 Direct ELISA

      2. 5.1.2 Indirect ELISA

      3. 5.1.3 Sandwich ELISA

      4. 5.1.4 Competitive ELISA

    2. 5.2 By Application

      1. 5.2.1 Disease diagnosis

      2. 5.2.2 Vaccine Development

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific

      2. 6.1.2 Abcam Plc

      3. 6.1.3 Merck KGaA

      4. 6.1.4 Bio-Rad Laboratories, Inc

      5. 6.1.5 Cell Biolabs, Inc

      6. 6.1.6 Promega Corporation

      7. 6.1.7 Zeus Scientific, Inc

      8. 6.1.8 Enzo-lifesciences, Inc

      9. 6.1.9 Arbor Assays, Inc

      10. 6.1.10 Biolegend, Inc

      11. 6.1.11 Agilient Technologies, Inc

      12. 6.1.12 J. Mitra & Co. Pvt Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Enzyme-Linked Immunosorbent Assay Market market is studied from 2019 - 2027.

The Global Enzyme-Linked Immunosorbent Assay Market is growing at a CAGR of >8% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Thermo Fisher Scientific , Bio-Rad Laboratories, Inc, Agilient Technologies, Inc , Merck KGaA, Promega Corporation are the major companies operating in Global Enzyme-Linked Immunosorbent Assay Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!